79 related articles for article (PubMed ID: 6094461)
1. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
Jones RN
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461
[TBL] [Abstract][Full Text] [Related]
2. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
Neu HC
Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
Wasilauskas BL
Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
Devlin HR; Boskovski L
Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species.
Canawati HN
Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
Aldridge KE; Sanders CV; Marier RL
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
[TBL] [Abstract][Full Text] [Related]
8. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Aldridge KE
Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
[TBL] [Abstract][Full Text] [Related]
10. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
Pitzus E
G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914
[TBL] [Abstract][Full Text] [Related]
11. Activity of cefotaxime and metronidazole against bacteroides and Escherichia coli alone and in mixed culture.
Soriano F; Ponte C; Santamaría M
J Antimicrob Chemother; 1983 Jul; 12(1):89-92. PubMed ID: 6311784
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
Aldridge KE; Weeks LS; Stratton CW; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
[TBL] [Abstract][Full Text] [Related]
13. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus.
Canawati HN
Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Jones RN; Barry AL; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination.
Nanetti A; La Placa M
J Chemother; 1990 Jun; 2(3):159-63. PubMed ID: 2380765
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of cefotaxime and desacetylcefotaxime against the Bacteroides fragilis group.
Cornick NA; Gorbach SL
Diagn Microbiol Infect Dis; 1988 Jun; 10(2):81-4. PubMed ID: 3224498
[TBL] [Abstract][Full Text] [Related]
19. Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.
Soriano F; Ponte MC
Antimicrob Agents Chemother; 1984 Jul; 26(1):39-41. PubMed ID: 6089653
[TBL] [Abstract][Full Text] [Related]
20. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
